Delivra Health Brands Management Commentary Attributes Fiscal 2026 Revenue Decline to Middle East Shipment Disruptions
Bitget2026/10/28 22:26- Delivra Health Brands management commentary linked lower revenue for the year ended June 30, 2026, to disrupted Middle East shipments.
- Revenue fell 35.5% to CAD 8.63 million, primarily reflecting weaker US Dream Water sales.
- Gross margin declined to 39% from 51%, reflecting customer and product mix changes, higher warehousing costs and e-commerce expenses.
- Adjusted EBITDA swung to a CAD 1.85 million loss as lower sales outweighed sales and marketing savings.
- Net loss widened to CAD 2.25 million from CAD 1.19 million.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Barclays: Bloom Energy (BE.US) demand turning point is steeper than expected, rating raised to "Buy"
Barclays has upgraded Bloom Energy’s rating from "equal weight" to "overweight," setting a target price of $289.
Competitor turns supplier as the "new owner"! Bank of America: Marvell Technology's acquisition of Lumentum may prompt Cisco and Ciena to seek other sources
Bank of America analysts stated that Marvell Technology's acquisition of Lumentum may prompt Ciena and Cisco to diversify their optical component suppliers.
Goldman Sachs traders warn of an "invisible bear market": S&P 500 is only 3% away from its all-time high, but 60% of its constituent stocks have entered bear market territory.
The S&P 500 Index is only about 3% away from its latest record high, but 60% of the constituent stocks in this benchmark index are deeply entrenched in bear market territory.
Crypto prices
More
